Skip To Main Content
Dario Baratti on Muck Rack

Dario Baratti

As seen in: MDPI, EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dario

Contact Dario, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal Cancers

|
By Dario Baratti, Carlo Galdino Riva, Marcello Guaglio, Tommaso Cavalleri
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Identification of patients with T4 colo-rectal cancer at different risk level for peritoneal metastases. Analysis of clinical, pathological and biological factors in a surgical series.

|
By Dario Baratti, Shigeki Kusamura, Marcello Guaglio, Gaia Colletti, Luca Sorrentino, Carlo Galdino Riva, Marcello Deraco
| EJSO - European Journal of Surgical Oncology Verified
Background: Different strategies to prevent peritoneal metastases from colorectal cancer (CRC-PM) have been tested in prospective trials with controversial results. However, risk factors for CRC-PM are still poorly understood. We sought to better define the risk associated with T4 stage CRC.
Open in Who Shared Issue with article?

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and HIPEC: the role of repeat surgery

|
By Marcello Guaglio, Dario Baratti, Shigeki Kusamura, Gaia Colletti, Luigi Battaglia, Massimo Milione, Tommaso Cavalleri, Marcello Deraco, Giovanna Sabella
| EJSO - European Journal of Surgical Oncology Verified
Background: The management of pseudomyxoma peritonei (PMP) patients relapsing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is not standardized. In particular, the role of repeat HIPEC is still undetermined. In our center, suitable patients with PMP relapse are treated by repeat CRS alone.
Open in Who Shared Issue with article?
See all 13 articles